MedPage Today on MSN
Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy
Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. | The ...
Applied Cells Inc. and Immuneel Therapeutics Private Limited today announced that the companies have entered into a collaboration framework to jointly evaluate application of Applied Cells' MARS(R) ...
This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...
Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Pharmaceutical Technology on MSN
AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy
The acquisition gives AstraZeneca full global control of the therapy’s development, manufacturing and commercialisation.
After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback